PODCAST NOW AVAILABLE! Click the link below to purchase access.
Future Challenges
for Laboratories & Diagnostics Companies
You don’t need to consult a remedial prognostication device to find out what the future holds for diagnostics companies and for the hospital and commercial clinical laboratories they serve.
Industry leaders from both the diagnostics and the laboratory industries shared their perspectives—what are the challenges and opportunities that await us, and how should we respond?
Many thanks to our featured panelists:
Frank R. Cockerill, MD Chair, Laboratory Medicine and Pathology Departments, The Mayo Clinic
Robert P. De Cresce, MD Chair of Pathology, Rush Medical Center
Dave Krul Senior Vice President, Global Marketing, Abbott Molecular
Tadd S. Lazarus, MD Medical Director, Medical and Scientific Affairs, Roche Diagnostics Corporation
Michael Richey President, Tethys Bioscience, Inc.
Jay T. Snyder VP, Global Marketing, Chemistry / Immunoassay / Automation, Siemens Healthcare Diagnostics
Click the Link Below to Purchase the On-Demand Download
PODCAST NOW AVAILABLE! Click the link below to purchase access.
